O-phosphorylation, O-adenylylation, or N-acetylation of the aminoglycoside molecule (2) . With the recognition of the biochemical basis of resistance, efforts have been directed towards the isolation and synthesis of compounds refractory to R-plasmid-mediated modification. This approach has been successful in providing butirosin (7) , amikacin (9) , and netilmicin (10)-aminoglycoside derivatives effective against certain classes of resistant bacteria since they are (apparently) not substrates for the enzymatic modifications involved.
Waitz et al. (12) have described a new semisynthetic derivative of sisomicin, 5-epi-sisomicin ( Fig. 1) , that has proved to be effective against a broad spectrum of aminoglycoside-resistant bacteria with known enzymatic mechanisms of resistance. Parallel studies by other workers have confirmed their conclusions (5, 8) . It was assumed that the antibacterial activity of the 5-epi derivative was due to the failure of the enzymes present in the resistant strains to modify this compound.
However, it had not been demonstrated whether 5-epi-sisomicin was active against resistant bacteria due to the inability of the Rplasmid-mediated enzymes to modify this com- 769, 1979) and sisomicin with 5-epi-sisomicin ( Fig. 1) as substrates for several aminoglycosidemodiffying enzymes and related these enzymatic data to the antimicrobial activity of the compounds.
MATERIALS AND METHODS
Bacterial strains used in these investigations are listed in Table 1 .
Antibiotics were obtained from Peter Daniels of the Schering Corp., and radioactively labeled substrates were obtained from commercial suppliers.
Enzyme assays and preparations of crude extracts were performed largely as described previously (6 were obtained by centrifugation at 50,000 x g for 2 h. Partially purified preparations of each of the aminoglycoside-modifying enzymes were obtained by the following procedure (all steps at 400). Streptomycin sulfate was added to the cell extract to give a final concentration of 1.5%; this mixture was stirred for 15 min and then centrifuged at 15,000 x g for 15 min. The enzyme was precipitated from the supernatant by the addition of ammonium sulfate to 55% saturation; this mixture was stirred for 1 h and then centrifuged at 15,000 x g for 156 min. The precipitate was dissolved in 3.0 ml of TMD buffer, sucrose was added to achieve a final concentration of 5% (wt/vol), and this solution was applied to a column of Sephadex G-100 (30.0 by 2.5 cm) equilibrated with TMD buffer. Elution with this same buffer was carried out at a flow rate of 10 to 20 ml per h and 60 2.0-mI fractions were collected and assayed for enzyme activity.
The aminoglycoside phosphotransferase (3') [APH(3')] and aminoglycoside adenylyltransferase (2") [ANT(2")] enzymes were assayed by the radiochemical assay (6) . The standard reaction mixture contained 1.0 mnM adenosine triphosphate (either 32P or 14C labeled) and 0.12 mM aminoglycoside, all in TMD buffer. The reaction was started by addition of enzyme to give a total reaction volume of 50 p1. The mixture was incubated at 300C for 15 min, and 20-1d samples were applied to 1-cm squares of Whatman P-81 phosphocellulose paper. These squares were washed three times in hot (70 to 800C) distilled water and dried, and the radioactivity was determined with a scintillation counter. Kinetic determinations were performed in the same manner by varying the aminoglycoside concentration in the reaction mixture.
Rate measurements for the aminoglycoside acetyltransferase enzymes were determined by means of the spectrophotometric assay by using the DTNB reaction (1). The standard reaction mixture contained 0.15 mM acetyl-coenzyme A, 0.12 mM aminoglycoside, and 1.0 mM DTNB all in TMD buffer. The reaction was started by the addition of enzyme to give a total volume of 1.0 ml. The reaction was followed at 412 nm at 250C, and the enzyme rate was determined from the molar extinction coefficient of 1.36 x 104 for the thionitrobenzoate anion liberated in the reaction (4). Kinetic determinations on the acetyl-transferases were performed by using the above conditions by varying the concentration of the aminoglycoside substrates.
Minimal inhibitory concentrations (MICs) were determined by in vitro dilution tests by using 2 (5, 8, 12 ). We have found that the presence of an AAC(6') enzyme resulted in bacterial resistance to sisomicin, gentamicin B, and both 5-epi compounds. The presence of an APH(3') enzyme gave resistance to gentamicin B and its 5-epi derivative. Surprisingly, however, we found that some enzymes, although able to modify the 5-epi compounds, did not confer resistance to these compounds. This apparent discrepancy was resolved by a more detailed study of the enzymes which showed significant differences in the efficacy with which the antibiotics are modified. The ANT(2"), AAC(3)-I, and AAC(2') enzymes have very much higher Km values for the modification of the 5-epi derivatives than they do for the parent compounds. This shows that that epimerization of the hydroxyl group at the 5-position of the 2-deoxystreptamine ring results in a substantially reduced rate of enzymatic modification; this reduction in modification rate must be responsible for sensitivity in strains possessing these enzymes. Thus, the ability of an R-plasmid-encoded resistance enzyme to catalyze antibiotic modification is not necessarily sufficient to determine resistance to aminoglycosides, but the modification must proceed at a certain minimum rate. This minimum rate cannot be ascertained with the standard radioenzymatic assay, with the result that the striking correlation between effective antibacterial concentration (MIC) and enzymatic activity (K,m) was not obvious from previous experiments.
In contrast to the differences noted above, the AAC(6') enzyme had similar Km values for all four compounds tested, and APH(3') also had a low Km value for both gentamicin B and 5-epigentamicin B. Thus, epimerization at the 5-position of 2-deoxystreptamine does not significantly affect the activity of all enzymes against their antibiotic substrates. However, different changes in aminoglycoside structure may well be effective in causing the appropriate reduction in enzymatic activity in other cases.
Since the establishment of aminoglycoside resistance by plasmid determined modifying enzymes is so dependent on (11) . In the light of our findings it should be profitable to examine additional aminoglycosides to find a compound which will act as a powerful inhibitor of the aminoglycoside-modifying enzymes. It is significant that the single change in the 5-epi compounds can affect at least three different forms of aminoglycoside modification-in fact, three of the most widely distributed and important in terms of resistance to this class of drugs. Thus, although there are several known types of aminoglycoside modification, these results lend hope to the thesis that other changes may also prove to be effective. In addition to synthetic derivatives, a search for naturally occurring inhibitors might be profitable, especially since the spectrophotometric assay for the aminoglycoside acetyltransferases can provide such a facile assay system.
Our results confirm and extend earlier proposals with respect to the mechanism of resistance to aminoglycoside antibiotics determined by Rplasmid encoded modifying enzymes. It is obvious that the rate and extent of aminoglycoside modification are of paramount importance in the establishment of resistance. If the Km for an antibiotic substrate is increased by as little as 10-fold the organism becomes susceptible (note that the 5-epi compounds have Km values 100 times higher in some cases). Whether an effective rate of modification of an aminoglycoside antibiotic is required to set up some kind of permeability block to stop the uptake of antibiotic into the cell, or if the rate of modification simply has to be sufficient to counteract the inefficient entry of the antibiotic into the cell, remains unclear (3) .
